Neuropsychological assessment allows for diagnosing cognitive and psychiatric disorders and generates cortical and autonomic nervous system (ANS) hypotheses.
Treatment targets are identified via matches between the symptom or deficit and the brain imaging and ANS findings. Medication and neuromodulation treatments are simulated in this vertical to determine if the treatment correctly modulates the neurophysiological activity to mitigate the patient’s symptoms or deficits.
Additional targets that cannot be seen on imaging, for example, microscopic malignant cells, can also be identified that via AI algorithms using this platform.
Cognitive Event Related Potentials allow us to compare the ERP results while the patient is completing various neuropsychological tests (Watch video!)
Quantitative PET – using traditional FDG to measure blood flow and glucose utilization in the brain as well as Amyloid and Tau PET (Watch video!)which allows our doctors to rule out Alzheimer’s disease (Watch video!)
Structural and volumetric vMRI using quantitative measures (Watch video!)
Listen in as Dr. Tramontano discuss and answer questions on the 3 Neuropsychological Profiles of AD: Typical, PCA, and Logopenic Aphasia.
Click the Image to download the PowerPoint
Register as a Patient Today
Get started on your journey to better health. Fill out our quick and secure registration form to access personalized care and support. Click below to register now.